362 related articles for article (PubMed ID: 17378912)
21. Aberrant methylation of genes in stool samples as diagnostic biomarkers for colorectal cancer or adenomas: a meta-analysis.
Luo YX; Chen DK; Song SX; Wang L; Wang JP
Int J Clin Pract; 2011 Dec; 65(12):1313-20. PubMed ID: 22093539
[TBL] [Abstract][Full Text] [Related]
22. Sensitivity and specificity of a stool DNA multitarget assay panel for the detection of advanced colorectal neoplasia.
Tagore KS; Lawson MJ; Yucaitis JA; Gage R; Orr T; Shuber AP; Ross ME
Clin Colorectal Cancer; 2003 May; 3(1):47-53. PubMed ID: 12777192
[TBL] [Abstract][Full Text] [Related]
23. Detection of methylated tissue factor pathway inhibitor 2 and human long DNA in fecal samples of patients with colorectal cancer in China.
Zhang J; Yang S; Xie Y; Chen X; Zhao Y; He D; Li J
Cancer Epidemiol; 2012 Feb; 36(1):73-7. PubMed ID: 21621497
[TBL] [Abstract][Full Text] [Related]
24. Detection of APC mutations in stool DNA of patients with colorectal cancer by HD-PCR.
Deuter R; Müller O
Hum Mutat; 1998; 11(1):84-9. PubMed ID: 9450908
[TBL] [Abstract][Full Text] [Related]
25. New method for colorectal cancer diagnosis based on SSCP analysis of DNA from exfoliated colonocytes in naturally evacuated feces.
Onouchi S; Matsushita H; Moriya Y; Akasu T; Fujita S; Yamamoto S; Hasegawa H; Kitagawa Y; Matsumura Y
Anticancer Res; 2008; 28(1A):145-50. PubMed ID: 18383838
[TBL] [Abstract][Full Text] [Related]
26. Testing of multiple samples increases the sensitivity of stool decay-accelerating factor test for the detection of colorectal cancer.
Mizuno M; Mizuno M; Iwagaki N; Nasu J; Okazaki H; Yamamoto K; Okada H; Tsuji T; Fujita T; Shiratori Y
Am J Gastroenterol; 2003 Nov; 98(11):2550-5. PubMed ID: 14638362
[TBL] [Abstract][Full Text] [Related]
27. Comparison of CT colonography, colonoscopy, sigmoidoscopy and faecal occult blood tests for the detection of advanced adenoma in an average risk population.
Graser A; Stieber P; Nagel D; Schäfer C; Horst D; Becker CR; Nikolaou K; Lottes A; Geisbüsch S; Kramer H; Wagner AC; Diepolder H; Schirra J; Roth HJ; Seidel D; Göke B; Reiser MF; Kolligs FT
Gut; 2009 Feb; 58(2):241-8. PubMed ID: 18852257
[TBL] [Abstract][Full Text] [Related]
28. Validity of new immunological human fecal hemoglobin and albumin tests in detecting colorectal neoplasms--an endoscopy-controlled study.
Sieg A; Scheida M; John MR; Hertel A; Schröter M; Lüthgens K; Schmidt-Gayk H
Z Gastroenterol; 1998 Jun; 36(6):485-90. PubMed ID: 9675833
[TBL] [Abstract][Full Text] [Related]
29. [Fecal methylated DNA for the detection of colorectal cancer].
von Delius S; Jung A; Schmid RM
Z Gastroenterol; 2006 Sep; 44(9):1001-2. PubMed ID: 16981074
[No Abstract] [Full Text] [Related]
30. GATA4 and GATA5 are potential tumor suppressors and biomarkers in colorectal cancer.
Hellebrekers DM; Lentjes MH; van den Bosch SM; Melotte V; Wouters KA; Daenen KL; Smits KM; Akiyama Y; Yuasa Y; Sanduleanu S; Khalid-de Bakker CA; Jonkers D; Weijenberg MP; Louwagie J; van Criekinge W; Carvalho B; Meijer GA; Baylin SB; Herman JG; de Bruïne AP; van Engeland M
Clin Cancer Res; 2009 Jun; 15(12):3990-7. PubMed ID: 19509152
[TBL] [Abstract][Full Text] [Related]
31. Detection of stool DNA mutations before and after treatment of colorectal neoplasia.
Syngal S; Stoffel E; Chung D; Willett C; Schoetz D; Schroy P; Jagadeesh D; Morel K; Ross M
Cancer; 2006 Jan; 106(2):277-83. PubMed ID: 16342248
[TBL] [Abstract][Full Text] [Related]
32. [Detection of fecal peroxisome proliferator-activated receptor delta and cyclooxygenase 2 mRNA in screening of colorectal cancer].
Yu H; Yang L; Yan F; Li Y; Sun X; Zhou Z
Zhonghua Wei Chang Wai Ke Za Zhi; 2014 Jan; 17(1):26-30. PubMed ID: 24519045
[TBL] [Abstract][Full Text] [Related]
33. A simplified, noninvasive stool DNA test for colorectal cancer detection.
Itzkowitz S; Brand R; Jandorf L; Durkee K; Millholland J; Rabeneck L; Schroy PC; Sontag S; Johnson D; Markowitz S; Paszat L; Berger BM
Am J Gastroenterol; 2008 Nov; 103(11):2862-70. PubMed ID: 18759824
[TBL] [Abstract][Full Text] [Related]
34. [Telomerase activity in stool of patients with colorectal cancer].
Luo C; Zhao D; Qu J
Zhonghua Wai Ke Za Zhi; 2001 Aug; 39(8):580-2. PubMed ID: 11758190
[TBL] [Abstract][Full Text] [Related]
35. Clinical performance of an automated stool DNA assay for detection of colorectal neoplasia.
Lidgard GP; Domanico MJ; Bruinsma JJ; Light J; Gagrat ZD; Oldham-Haltom RL; Fourrier KD; Allawi H; Yab TC; Taylor WR; Simonson JA; Devens M; Heigh RI; Ahlquist DA; Berger BM
Clin Gastroenterol Hepatol; 2013 Oct; 11(10):1313-8. PubMed ID: 23639600
[TBL] [Abstract][Full Text] [Related]
36. Nucleic acids from intact epithelial cells as a target for stool-based molecular diagnosis of colorectal cancer.
Spethmann S; Fischer C; Wagener C; Streichert T; Tschentscher P
Int J Mol Med; 2004 Mar; 13(3):451-4. PubMed ID: 14767578
[TBL] [Abstract][Full Text] [Related]
37. A highly sensitive method for the detection of p16 methylation in the serum of colorectal cancer patients.
Nakayama G; Hibi K; Nakayama H; Kodera Y; Ito K; Akiyama S; Nakao A
Anticancer Res; 2007; 27(3B):1459-63. PubMed ID: 17595762
[TBL] [Abstract][Full Text] [Related]
38. Reproducibility of a multitarget stool-based DNA assay for colorectal cancer detection.
Brand RE; Ross ME; Shuber AP
Am J Gastroenterol; 2004 Jul; 99(7):1338-41. PubMed ID: 15233675
[TBL] [Abstract][Full Text] [Related]
39. A sensitive method to quantify human long DNA in stool: relevance to colorectal cancer screening.
Zou H; Harrington JJ; Klatt KK; Ahlquist DA
Cancer Epidemiol Biomarkers Prev; 2006 Jun; 15(6):1115-9. PubMed ID: 16775168
[TBL] [Abstract][Full Text] [Related]
40. [Detection of protein p53 in the stool of patients with colorectal cancer].
Jaïs P; Kapel N; Chosidow D; Rupaire N; Rougier P; Lasser P; Mignon M; Lewin MJ; Gobert JG
Gastroenterol Clin Biol; 1997; 21(10):754-9. PubMed ID: 9587516
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
